结论：东菱克栓酶是治疗糖尿病足有效药物。
Conclusion: Batroxobin is an effective medicine for cure diabetic foot.
目的探讨蝮蛇抗栓酶治疗突发性耳聋的效果。
Objective To discuss the effect of SVATE on sudden deafness.
结论：巴曲抗栓酶治疗ami是安全有效的。
CoNCLUSION: Batroxobin is safe and effective for the treatment of AMI.
结论蝮蛇抗栓酶对重度黄疸肝炎有良好的疗效。
Conclusion Agkistrodon halys anti-embolism enzyme has significant effect to the severe icteric hepatitis.
蝮蛇抗栓酶组疗效明显高于对照组（P<0.05）。
The curative effect in the test group is much better than that in the control group (P<0.05).
用蝮蛇抗栓酶治疗急性脑梗死52例，有效率达98％。
The total clinical effect was 98% for 52 cases of acute cerebral infarction treated with ahalysantinfactasum.
目的观察东菱克栓酶治疗血液病合并高粘血症的临床疗效。
Objective to observe the effects of batroxobin in the treatment of hematologic diseases complicated with high ropiness (or thrombosis).
东菱精纯克栓酶是一种单成分溶血栓促微循环的新型血栓治疗剂。
Batroxobin is a new thrombolytic drug, which is made up of single composition and can improve the blood microcirculation.
目的观察低分子肝素钙联合东菱克栓酶治疗进展性脑梗死的疗效。
Objective To observe the therapeutic efficacy of combination of low-molecular weight heparin and Batroxobin(DF-521)on progressive stroke.
目的探讨东菱克栓酶治疗急性脑梗死对凝血与纤溶系统的影响及意义。
Objective To explore the effects of Batroxobin on coagulation and fibrinolytic system in patients with acute cerebral infarction.
目的观察并了解东菱精纯克栓酶对荷瘤裸鼠全血流变学参数值的影响。
Objective To observe the effects of Batroxobin on the hemorheology in the whole blood of Nude mice with gastric and nasopharynegal carcinoma.
蝮蛇抗栓酶从蝮蛇蛇毒提取的具有降低纤维蛋白原和血液粘滞度的物质。
Ahylysantinfarctase from snake venom extract with lower fibrinogen and blood viscosity of the material.
目的探讨急性脑梗塞患者用东菱克栓酶治疗对其凝血与纤溶系统的影响。
Objective To explore the effects of Batroxobin on coagulation and fibrinolytic system in the patients with acute cerebral infarction.
目的观察东菱精纯克栓酶(DF- 521)治疗爆震性耳聋的临床疗效。
Objective To observe the clinical effect of batroxobin (DF-521) in the treatment of explosion hearing loss.
目的实验研究克栓酶的抑瘤作用，以期扩展其药用范围，为治疗肿瘤增加药源。
Objective to research the Batroxobin DF 521 effect on inhibition of tumor in order to extend its useful range and provide a new drug for curing tumor.
本发明的豆豉溶栓酶经处理后可制成溶血栓类药品和预防心血管疾病的保健食品。
The fermented soybean streptokinase ofthe present invention after being treated may be produced into thrombus dissolving medicine and health food for preventing cardiac and cerebral vascular diseases.
目的：观察东菱精纯克栓酶（DF- 5 2 1）对豚鼠爆震性听损伤的影响。
Objective: To observe the protective effect of batroxobin(DF-521) on blast-induced hearing loss in guinea pigs.
本文报告用清栓酶治疗突聋48例的疗效观察。其中男40例，女8例，总有效率为88％。
This paper reports the effects of ophiotoxin(Qingshaunmei) in the treatment of 48 cases of sudden deaf.
治疗组在同对照组治疗的基础上，于第1、3、5天分别给予东菱克栓酶10BU、5BU、5BU。
The therapy group, Batroxobin 10BU, 5BU , 5BU were adminiatated at 1,3,5 days after diagnosis.
结论：精纯抗栓酶与降纤酶这两种蛇毒制剂的疗效相近，使用后使纤维蛋白原降低的作用时间均较短。
Conclusion: Ahalsantinfarctasel and Difibrinogenase have almost equal curative effect and both have the short effective duration to reduce the fibrinogen.
方法将7年的蝮蛇抗栓酶治疗组28例30耳，与扩管药物治疗组28例30耳，进行回顾性对比分析。
Methods the retrospective study of 28 cases (30 ears) treated with SVATE was conducted and compared, with 28cases (30 ears) treated with other drug.
蛇毒抗栓酶组在120分钟血凝块大部分溶解，而对照组120分钟血凝块溶解不明显，显示了蛇毒抗栓酶具有明显的溶栓效应。
The clot appeared to lyse at 120 min. But the clot to lyse of control not appeared at 120 min. This observation indicated that A.
借助于此方法，一些临床上重要的酶和蛋白如小牛血清白蛋白、溶栓酶、糜蛋白酶、中性蛋白酶、葡萄糖氧化酶（GOD）等已能被很好的固定。
Several clinically important enzymes and proteins that include bovine serum albumin, streptokinase, chymotrypsin, dispase, glucose oxidase (GOD) etc. , have been immobilized based on this method.
目的探讨降纤酶对脑梗死的溶栓效果、用药时间窗及安全性。
Objective To discuss the thrombolysis effect, drug using window, and safety for cerebral infarction.
结论：溶栓后补救性PCI可能使心肌酶增高，死亡率增加。
Conclusions: Rescue-PCI could increase mortality rate and the value of cardiac enzymes.
目的观察海洋假单胞菌碱性蛋白酶（MPAP）的溶栓和抑制血栓形成的作用，研究其对纤溶、凝血和血小板聚集功能的影响。
ObjectiverTo observe the thrombolysis and anti-thrombosis effects of MPAP; To study the actions of MPAP on blood coagulation, platelet aggregation and fibrinolytic activity.
目的：为进一步确认海洋假单胞菌碱性蛋白酶(mpap)的纤溶性质，并观察其抗栓作用。
Objective To further study the characteristics of fibrinolytic activity and the thrombolytic effect of MPAP.
目的适时合理选择急性心肌梗死(ami)溶栓疗效判断中血清酶学指标。
Objective To select reasonable time of determining serum enzymes in assessing the efficacy of thrombolytic therapy in patients with acute myocardial infarction (AMI).
目的适时合理选择急性心肌梗死(ami)溶栓疗效判断中血清酶学指标。
Objective To select reasonable time of determining serum enzymes in assessing the efficacy of thrombolytic therapy in patients with acute myocardial infarction (AMI).
应用推荐